One of the best resources for investors are the publicly available 13F-HR documents that each fund is required to submit to the SEC. These documents allow investors to track their favorite superinvestors, their fund’s current holdings, plus their new buys and sold out positions. We spend a lot of time here at The Acquirer’s Multiple digging through these 13F-HR documents to find out which superinvestors hold positions in the stocks listed in our Stock Screeners.
As a new weekly feature, we’re now providing the top 10 holdings from some of our favorite superinvestors based on their latest 13F-HR documents.
This Tiger Cub Giant Is Betting On Banks And Tech Stocks In The Recovery
The first two months of the third quarter were the best months for D1 Capital Partners' public portfolio since inception, that's according to a copy of the firm's August update, which ValueWalk has been able to review. Q2 2020 hedge fund letters, conferences and more According to the update, D1's public portfolio returned 20.1% gross Read More
This week we’ll take a look at superinvestor John Paulson (6-30-2020). The current market value of his portfolio is $3,129,242,000, with a top 10 holdings concentration of 79.25%.
John Paulson's Top 10 Holdings
|Stock||Shares||Market Value||% of
|BHC / Bausch Health Companies||25,839,035||$472,596,000||15.2|
|HZNP / Horizon Therapuetics PLC||6,891,439||$383,026,000||12.32|
|GLD / SPDR Gold Trust||1,894,252||$317,041,000||10.2|
|BSIG / BrightSphere Investment Group||20,000,552||$249,207,000||8.02|
|TAK / Takeda Pharmaceutical Co||11,486,905||$205,960,000||6.62|
|AU / AngloGold Ashanti Ltd||6,974,331||$205,673,000||6.61|
|NG / Novagold Resources Inc||22,226,300||$204,037,000||6.56|
|MYL / Mylan N.V.||11,478,260||$184,570,000||5.94|
|DISCK / Discovery Communications, Inc.||6,902,805||$132,948,000||4.28|
|DISH / DISH Network Corp||3,620,750||$124,952,000||4.02|
Impact on Portfolio
|BHC / Bausch Health Companies||2.78|
|AMTD / TD AmeriTrade Holding Corp.||1.13|
|EQX / Equinox Gold Corp||0.90|
|QGEN / Qiagen N.V.||0.77|
|TCO / Taubman Centers, Inc.||0.36|
Impact On Portfolio
|AGN / Allergan Plc||4.069|
|VIAC / ViacomCBS Inc||2.038|
|DISCK / Discovery Inc Series C||1.94|
|S / Sprint Corp||1.665|
|TAK / Takeda Pharmaceutical Co||1.09|
For more articles like this, check out our recent articles here.